Walleye Capital’s Zimmer Biomet ZBH Stock Holding History

Walleye Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$90.4K	Sell	1,000 -10,400	-91%	-$954K	﹤0.01%	3706
2025 Q4	$1.03M	Buy	11,400 +7,200	+171%	+$683K	﹤0.01%	2407
2025 Q3	$414K	Buy	4,200 +1,500	+56%	+$149K	﹤0.01%	2773
2025 Q2	$246K	Buy	+2,700	New	+$261K	﹤0.01%	3203
2025 Q1	–	Sell	-15,900	Closed	-$1.68M	–	5260
2024 Q4	$1.68M	Buy	15,900 +600	+4%	+$64.4K	﹤0.01%	1944
2024 Q3	$1.65M	Sell	15,300 -20,700	-58%	-$2.26M	﹤0.01%	2150
2024 Q2	$3.91M	Buy	36,000 +23,600	+190%	+$2.78M	0.01%	1487
2024 Q1	$1.64M	Buy	12,400 +7,200	+138%	+$899K	﹤0.01%	2149
2023 Q4	$633K	Sell	5,200 -5,300	-50%	-$591K	﹤0.01%	2756
2023 Q3	$1.18M	Buy	10,500 +5,200	+98%	+$660K	﹤0.01%	2141
2023 Q2	$772K	Buy	+5,300	New	+$720K	﹤0.01%	2068
2022 Q4	–	Sell	-300	Closed	-$31K	–	3696
2022 Q3	$31K	Buy	+300	New	+$32.9K	﹤0.01%	2669
2020 Q1	–	Sell	-2,060	Closed	-$299K	–	1774
2019 Q4	$299K	Sell	2,060 -7,519	-78%	-$1.04M	0.02%	925
2019 Q3	$1.28M	Buy	+9,579	New	+$1.24M	0.08%	355
2019 Q2	–	Sell	-3,296	Closed	-$409K	–	2115
2019 Q1	$409K	Buy	+3,296	New	+$375K	0.07%	460

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Capital's ZBH Position: Q1 2026 in Review

Walleye Capital reduced its Zimmer Biomet (ZBH) stake by 33% in Q1 2026, selling an estimated $244K and leaving 5,445 shares worth $492K. The position accounts for ﹤0.01% of the portfolio, ranked #2684.

Walleye Capital first reported a position in ZBH in Q4 2019 and has held it in 13 quarters since. The position peaked at $15.5M in Q3 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Walleye Capital held 5,445 shares of Zimmer Biomet worth $492K as of Q1 2026.
Walleye Capital sold 2,657 Zimmer Biomet shares in Q1 2026, an estimated $244K.
Zimmer Biomet made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #2684 holding.
Walleye Capital first reported a position in Zimmer Biomet in Q4 2019 and has held it in 13 quarters since.
Walleye Capital's Zimmer Biomet position peaked at $15.5M in Q3 2023.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.